The Company performed a qualitative impairment analysis on its long-lived assets, including theater properties and right-of-use assets, as of September 30, 2026. As a result of the qualitative assessment, the Company noted no impairment indicators related to these assets as of September 30, 2026.

See Note 1 and Note 10 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed February 18, 2026, for further discussion of the Company’s impairment policy and a description of the qualitative and quantitative impairment assessments performed.

There were no impairment charges recorded for long-lived assets for the three and nine months ended September 30, 2026. We recorded total impairment charges for long-lived assets of $0.6 and $2.2 for the three and nine months ended September 30, 2025.